May 7, 2024
James Helzberg
Share
Article Link: https://pubmed.ncbi.nlm.nih.gov/36626622/
What regimens are most effective for induction and maintenance therapy for patients with autoimmune hepatitis?
April 1, 2022
A new second-line therapy for Primary Biliary Cholangitis: Elafibranor
December 13, 2024
Are we getting closer to liver dialysis for acute-on-chronic alcohol-related liver failure?
